X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NVCR

Closed

Novocure Ltd

17.88
+0.08 (+0.45%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 17.8
Day's Range: 17.525 - 18.605
Send
When Written:
 
63.01
Novocure Ltd is a global oncology company that develops and commercializes innovative therapies for cancer patients. The company's proprietary therapy, Tumor Treating Fields (TTFields), is a non-invasive treatment that uses electric fields to disrupt cancer cell division and inhibit tumor growth. The therapy is approved for the treatment of glioblastoma, a type of brain cancer, and mesothelioma, a type of cancer that affects the lining of the lungs and abdomen.

Novocure was founded in 2000 and is headquartered in Jersey, Channel Islands. The company has operations in the United States, Europe, and Asia and employs over 1,000 people worldwide. Novocure's mission is to extend survival and improve quality of life for cancer patients by developing and commercializing innovative therapies that target the underlying biology of cancer.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X